gatifloxacin has been researched along with Lymphoma, B-Cell, Marginal Zone in 1 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
Lymphoma, B-Cell, Marginal Zone: Extranodal lymphoma of lymphoid tissue associated with mucosa that is in contact with exogenous antigens. Many of the sites of these lymphomas, such as the stomach, salivary gland, and thyroid, are normally devoid of lymphoid tissue. They acquire mucosa-associated lymphoid tissue (MALT) type as a result of an immunologically mediated disorder.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hori, K | 1 |
| Suguro, M | 1 |
| Koizuka, H | 1 |
| Sakagami, T | 1 |
| Tomita, T | 1 |
| Kosaka, T | 1 |
| Fukuda, Y | 1 |
1 other study available for gatifloxacin and Lymphoma, B-Cell, Marginal Zone
| Article | Year |
|---|---|
Disappearance of rectal mucosa-associated lymphoid tissue lymphoma following antibiotic therapy.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Female; Fluoroquinolones; Gastritis; Gatifloxacin; H | 2004 |